AWA
PRTK

Arete Wealth Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Arete Wealth Advisors’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,050
Closed -$36K – 773
2023
Q1 		$36K Hold
14,050
– – ﹤0.01% 629
2022
Q4 		$26.3M Buy
+14,050
New +$26.3M ﹤0.01% 611